Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinosarcoma × cediranib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 13 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 9 Glioblastoma 8 Colorectal Neoplasms 8 Fallopian Tube Neoplasms 7 Breast Neoplasms 7 Rectal Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Gliosarcoma 6 Colonic Neoplasms 6 Brain Neoplasms 6 Carcinoma, Renal Cell 5 Melanoma 4 Uterine Cervical Neoplasms 3 Sarcoma, Alveolar Soft Part 3 Sarcoma 3 Prostatic Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms, Male 3 Uveal Melanoma 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1

Interventions

Specimen Handling 8 Paclitaxel 6 Magnetic Resonance Spectroscopy 6 Nivolumab 5 Carboplatin 5 Biopsy 5 pembrolizumab 3 X-Rays 3 olaparib 2 ceralasertib 2 Taxes 2 trastuzumab deruxtecan 1 sargramostim 1 rucaparib 1 ribociclib 1 pelcitoclax 1 pazopanib 1 pamiparib 1 durvalumab 1 cobimetinib 1 cediranib 1 cabozantinib 1 belinostat 1 atezolizumab 1 Tissue Banks 1 TIC10 compound 1 Radiation 1 Phantoms, Imaging 1 Minimally Invasive Surgical Procedures 1 LY-2157299 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown

GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡